ISRCTN61646154已完成未知
The effect of sitagliptin on myocardial performance in patients with type 2 diabetes and coronary artery disease
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/24503784
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Patients (male and female participants who are over the age of 18 years) with type 2 diabetes on metformin, sulphonylureas or thiazolidinediones and known to have coronary artery disease will be invited to participate in the study.
排除标准
- •1. Patients with resting LV dysfunction (ejection fraction <40% or regional wall motion abnormalities)
- •2. History of myocardial infarction within the preceding 3 months
- •3. Significant myocardial hypertrophy, valve disease or conduction abnormality
- •4. Pacemaker
- •5. Diabetes receiving insulin or exenatide therapy
- •6. Renal impairment (serum creatinine > 175 µmol/l)
- •7. Severe co-morbid illness
- •8. Women of childbearing potential
研究者
相似试验
进行中（未招募）
不适用
The effect of sitagliptin on myocardial performance in patients with type 2 diabetes and coronary artery disease. - The effect of sitagliptin on LV performance in diabeticsCoronary artery diseaseMedDRA version: 9.1Level: HLTClassification code 10011085Term: Ischaemic coronary artery disordersMedDRA version: 9.1Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentEUCTR2009-012776-27-GBCambridge University Hospitals NHS Foundation Trust and University of Cambridge20
已完成
不适用
Effect of Sitagliptin on Myocardial function in type-2 diabetic patients complicated by congestive heart failureJPRN-UMIN000012490Department of Cardiology, Osaka Medical College15
招募中
不适用
Effect of Sitagliptin on Plaques and Cardiac Function following ACSAcute Coronary Syndrome end Type 2 Diabetes MellitusJPRN-UMIN000007900ESPECIAL-ACS office46
已完成
不适用
Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 DiabetesType 2 DiabetesCardiovascular DiseaseNCT01951339University of Colorado, Denver36
进行中（未招募）
不适用
The effects of sitagliptin (Januvia) on myocardial performance in patients with coronary artery disease and diabetescoronary artery disease and type 2 diabetes mellitusMedDRA version: 9.1Level: HLTClassification code 10011085Term: Ischaemic coronary artery disordersMedDRA version: 9.1Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentEUCTR2008-000300-89-GBCambridge University Hospitals NHS Foundation Trust